BOT.AX Gross Margin

The Gross Margin of Botanix Pharmaceuticals Ltd (BOT.AX) is 36.99%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BOT.AX Gross Margin - Historical Value

Date	Value
2025-06-30	36.99%
2024-06-30	-51.99%
2023-06-30	-274.18%
2022-06-30	4.51%

BOT.AX Gross Margin - Peers Comparison

Ticker	Name	Value
AGH.AX	Althea Group Holdings Ltd	48.43%
IHL.AX	Incannex Healthcare Ltd	48.23%
NYR.AX	Nyrada Inc	-348.25%
PAA.AX	Neurizon Therapeutics Ltd	79.81%
SPL.AX	Starpharma Holdings Ltd	79.08%
AC8.AX	Auscann Group Holdings Ltd	100.00%
ECS.AX	ECS Botanics Holdings Ltd	29.86%
IDT.AX	IDT Australia Ltd	69.19%
IXC.AX	Invex Therapeutics Ltd	7775.20%
RCE.AX	Recce Pharmaceuticals Ltd	-207.65%
WFL.AX	Wellfully Ltd	53.07%
ZLD.AX	Zelira Therapeutics Ltd	-1237.88%
PXS.AX	Pharmaxis Ltd	85.23%
4586.T	Medrx Co Ltd	99.88%
LGP.AX	Little Green Pharma Ltd	66.30%
NEU.AX	Neuren Pharmaceuticals Ltd	18.56%
RNO.AX	Rhinomed Ltd	74.82%
ACR.AX	Acrux Ltd	100.00%
ANP.AX	Antisense Therapeutics Ltd	97.91%
CGB.AX	Cann Global Ltd	-13.90%
CAN.AX	Cann Group Ltd	68.16%
IVX.AX	Invion Ltd	29.51%
MXC.AX	MGC Pharmaceuticals Ltd	37.98%
204840.KQ	GL Pharm Tech Corp	39.57%
AVE.AX	Avecho Biotechnology Ltd	59.32%